All Episodes
The Immunobuddies — 217 episodes
Episode 217: Time of Day Impact on Immunotherapy Outcomes - is NLR a key to the time lock Part 2 Dr Alfred So (On behalf of NOTCH)
Episode 216: Time of Day Impact on Immunotherapy Outcomes - Circadian Rhythm Part 1 Dr Alfred So (On behalf of NOTCH)
Episode 215: ADC's are eating Breast Cancer. An ADC Revolution - What's next? Final Part with Dr Jay Naik Consultant Medical Oncologist
Episode 214: ADC's are eating Breast Cancer. An ADC Revolution - Does the Payload really matter? Part 3 with Dr Jay Naik Consultant Medical Oncologist
Episode 213: ADC's are eating Breast Cancer. An ADC Revolution Part 2 with Dr Jay Naik Consultant Medical Oncologist
Episode 212: ADC's are eating Breast Cancer. An ADC Revolution - Breast Cancer Refined Part 1 with Dr Jay Naik Consultant Medical Oncologist
Episode 211 : PATIENT PODCAST 8 Want To Know, Forgot To Ask! - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 210 : PATIENT PODCAST 7 Advice on Family, Friends and Career - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 209 : PATIENT PODCAST 6 Tips To Help Yourself - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 208 : PATIENT PODCAST 5 Managing Side Effects - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 207 : PATIENT PODCAST 4 Side Effects Explained - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 206 : PATIENT PODCAST 3 Practicalities of Immunotherapy - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 205 : PATIENT PODCAST 2 Understanding Medical Jargon - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 204 : PATIENT PODCAST Basics of Immunotherapy - Video link available through www.theimmunobuddies.com for Patients, Caregivers and HCP's
Episode 203: Metastatic Disease Refractory Setting Final Part Bladder Cancer With Associate Professor Will Ince
Episode 202: Bladder Cancer Reimagined - Part 4 - Metastatic Disease and the Evolution of ADC and Checkpoint Inhibitor Synergy With Associate Professor Will Ince
Episode 201: Bladder Cancer Reimagined - Part 3 - Muscle Invasive Perioperative Approach With Associate Professor Will Ince
Episode 200: Bladder Cancer Reimagined - Part 2 - Muscle Invasive With Associate Professor Will Ince
Episode 199: Bladder Cancer Reimagined - Non Muscle Invasive With Associate Professor Will Ince
Episode 198 : The role of Supportive Care in optimising immunotherapy and cancer outcomes Final Part with Dr Dan Monnery Clatterbridge Cancer Centre
Episode 197 : The role of Supportive Care in optimising immunotherapy and cancer outcomes Part 2 with Dr Dan Monnery Clatterbridge Cancer Centre
Episode 196 : The role of Supportive Care in optimising immunotherapy and cancer outcomes Part 1 with Dr Dan Monnery Clatterbridge Cancer Centre
Episode 195: Can Exercise Boost Immunotherapy? Muscles, Myokines & the Tumour Microenvironment Final Part With Dr David Bartlett Exercise Immunologist University of Surrey
Episode 194: Can Exercise Boost Immunotherapy? Muscles, Myokines & the Tumour Microenvironment Part 2 With Dr David Bartlett Exercise Immunologist University of Surrey
Episode 193: Can Exercise Boost Immunotherapy? Muscles, Myokines & the Tumour Microenvironment Part 1 With Dr David Bartlett Exercise Immunologist University of Surrey
Episode 192: A new era for Medical Oncology with our very own Immunobuddies star Professor Anna Olsson - Brown
Episode 191; IKCS Special! PRISM Trial - A game changer for Renal Cancer 2 Part Special (Part 2) Naveen Vasudev
Episode 190: IKCS Special! PRISM Trial - A game changer for Renal Cancer 2 Part Special (Part 1) Naveen Vasudev
Episode 189 Immunotherapy on the Acute Take Part 3: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician
Episode 188 Immunotherapy on the Acute Take Part 2: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician
Episode 187 Immunotherapy on the Acute Take: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician
Episode 186: Final Part Autoimmune Pre-existing Neurological Disorders with Professor of Medicine Doug B. Johnson Vanderbilt Nashville
Episode 185 Autoimmune Pre-existing Neurological Disorders with Professor of Medicine Doug B. Johnson Vanderbilt Nashville
Episode 184: RS3PE A WIFI password from the 90's or an actual toxicity Final Part
Episode: 183 RS3PE A WIFI password from the 90's or an actual toxicity Part 3
Episode 182: RS3PE - A WIFI password from the 90's or an actual toxicity? Investigations Explored
Episode 181: RS3PE - A WIFI password from the 90's or an actual toxicity?
Episode 180: Impact of Diet on Immunotherapy and Practical Approaches Final Part with Immunotherapy Dietician Raiatea Van-Reenen University Hospital Derby
Episode 179: Impact of Diet on Immunotherapy and Practical Approaches Part 3 with Immunotherapy Dietician Raiatea Van-Reenen University Hospital Derby
Episode 178: Impact of Diet on Immunotherapy and Practical Approaches Part 2 with Immunotherapy Dietician Raiatea Van-Reenen University Hospital Derby
Episode 177: Impact of Diet on Immunotherapy and Practical Approaches with Immunotherapy Dietician Raiatea Van-Reenen University Hospital Derby
Episode 176: Immunotherapy in Older Patients with Dr Nicolo Battista and Dr Mark Baxter - If I won the lottery
Episode 175: Immunotherapy in Older Patients with Dr Nicolo Battista and Dr Mark Baxter
Episode 174: Final Part Low Dose Immunotherapy with Dr Pablo Jimenez Royal Marsden - Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L) 1 inhibitor strategies
Episode 173: Low Dose Immunotherapy with Dr Pablo Jimenez Royal Marsden - Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L) 1 inhibitor strategies
Episode 172: Clinical Application of the Microbiome Final Part with International Expert Professor Monty Pal City of Hope California
Episode 171: Clinical Application of the Microbiome with International Expert Professor Monty Pal City of Hope California
Episode 170: New Immunotherapies for Community Teams and Non-Oncologists Final Part with Macmillan GP Lead for Wales Dr Elise Lang
Episode 169: New Immunotherapies for Non Oncologists and Community Teams Part 3 with Macmillan GP Lead for Wales Dr Elise Lang
Episode 168: New Immunotherapies for Community Teams and Non Oncologists Part 2 with Macmillan GP Lead for Wales Dr Elise Lang
Episode 167: New Immunotherapies for Community Teams and Non Oncologists Part 1 with Macmillan GP Lead for Wales Dr Elise Lang
Episode 166: Real World Complex Case Part 6 - Learning points in each episode with Dr Jay Naik
Episode 165: Real World Complex Case Part 5 - Learning points in each episode with Dr Jay Naik
Episode 164: Real World Complex Case Part 4 - Learning points in each episode with Dr Jay Naik
Episode 163: Real World Complex Case Part 3 - Learning points in each episode with Dr Jay Naik
Episode 162: Real World Complex Case Part 2 - Learning points in each episode with Dr Jay Naik
Episode 161: Real World Complex Case 1 - Learning points in each episode with Dr Jay Naik
Episode 160: Role of Immunotherapy in Metastatic Triple Negative Breast Cancer
Episode 159: Triple Negative Breast - Role of Complete Pathological Response and impact on Surgery
Episode 158: Triple Negative Breast 2 Role of Immunotherapy in Neoadjuvant and Adjuvant Space
Episode 157: Overview of Triple Negative Breast Cancer with Dr Peter Hall
Episode 156: Cancer Vaccine from a Surgical Perspective with Professor Rob Jones Research Lead for Advanced Colorectal Cancer
Episode 155: Surgical Primer Final Part - Putting a knife in to the heart of immunotherapy with Professor Rob Jones Research Lead for Advanced Colorectal Cancer
Episode 154: Surgical Primer - Putting a knife to the heart of immunotherapy with Professor Rob Jones Research Lead for Advanced Colorectal Cancer
Episode 153: Subcutaneous Immunotherapy Treatment - Future Potential with Jo Parkes and Dr Vasiliki Michalarea
Episode 152: Subcutaneous Immunotherapy Treatment - Logistics with Jo Parkes and Dr Vasiliki Michalarea
Episode 151: Subcutaneous Immunotherapy Treatment - Game Changer or Gimmick? With Jo Parkes and Dr Vasiliki Michalarea
Episode 150 HLH Final Part - Management
Episode 149: HLH - H score demystified Part 4
Episode 148: HLH Approach and Investigations Part 3
Episode 147: HLH Part 2
Episode 146: HLH Demystified! Not Another Triad of Doom!
Episode 145: Manifest! Endless Potential! The Future of Predictive Biomarkers for Treatment Response and Toxicity with Dr Zayd Tippu Crick Institute Final Part
Episode 144: Manifest- Devils Advocate! The Future of Predictive Biomarkers for Treatment Response and Toxicity with Dr Zayd Tippu Crick Institute Part 2
Episode 143: Manifest! The Future of Predictive Biomarkers for Treatment Response and Toxicity with Dr Zayd Tippu Crick Institute
Episode 142: Immunotherapy Reimagined Final Part - Taking a BITE out of the cancer cell
Episode 141: Immunotherapy Reimagined - The Misnomer of Cancer Vaccines
Episode 140: Immunotherapy Reimagined Part 2 - Beyond Checkpoint Inhibitors
Episode 139: Immunotherapy Reimagined! I thought it was all about Checkpoint Inhibitors?
Episode 138: Practical Ophthalmology - Lotions and Potions Final Part - Rapid Fire Eye Complications of IO induced Systemic Syndromes With Dr Nima Ghadir Medical Ophthalmologist
Episode 137: Practical Ophthalmology - Lotions and Potions Part 2 - Focus on Pain and Sore Eyes With Dr Nima Ghadir Medical Ophthalmologist
Episode 136: Practical Ophthalmology - Lotions and Potions - Focus on Dry Eyes With Dr Nima Ghadir Medical Ophthalmologist
Episode 135: New and Novel Immunotherapy - ICANS - Practical Approach to Management with Dr. Frederick Vonberg Institute of Neurology University College London
Episode 134: New and Novel Immunotherapy - Demystifying ICANS - Overview, Mechanism of Toxicity and Mimics with Dr. Frederick Vonberg Institute of Neurology University College London and Harvard Medical School
Episode 133: Exploration immunotherapy in Merkel Cell and Basal Cell Carcinoma with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany
Episode 132: Exploration of new immunotherapy approaches in Skin Cancers with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany
Episode 131: All Skin Cancer Demystified. Is Neoadjuvant Immunotherapy really the panacea? with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany
Episode 130: Lung Cancer (Mesothelioma) Immunotherapy Toxicities and Future with Dr Adam Januszewski
Episode 129: Lung Cancer (Mesothelioma) Role Of Immunotherapy with Dr Adam Januszewski
Episode 128: Lung Cancer (Mesothelioma) with Dr Adam Januszewski
Episode 127: Personalised Immunotherapy Final Part - the future potential with Dr Paolo Ascierto
Episode 126: Personalised Immunotherapy - How do we apply in real world practice? With Dr Paolo Ascierto
Episode 125: Personalised Immunotherapy - What does this mean? With Dr Paolo Ascierto Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples (Italy)
Episode 124: Curenetics Final Part - The Bonus episode - A first for the immunobuddies! How should we apply the tool to future clinical trials?
Episode 123: Curenetics Part 3 - Can we apply to Toxicity Prediction and how do we integrate this tool in future?
Episode 122: Curenetics Part 2 Practical Applications of the 4 Components to Predict response to checkpoint inhibitors in the real world
Episode 121: Christmas Special - Curenetics - Can we use AI to Predict Response to Checkpoint Inhibitor Immunotherapy? With Founder and CMO Dr Sola Adeleke and Team
Episode 120: Uveal Melanoma and the Data that supports the Newly NICE Approved Tebentafusp and Future Developments with Dr Joe Sacco
Episode 119: Uveal Melanoma and the Role of Immunotherapy in metastatic disease with Dr Joe Sacco
Episode 118: Ocular (Uveal and Conjunctival) Melanoma and the Role of Immunotherapy Demystified with Dr Joe Sacco
Episode 117: Gastro Toxicities with Professor Nick Powell - Role of endoscopy and how to approach the conversation!
Episode 116: Gastro Toxicities with Professor Nick Powell - Role of topical steroids, Infliximab
Episode 115: Gastro Toxicities with Professor Nick Powell - Role of steroids, timing and duration
Episode 114: The role of Genomics and Genetics in predicting Immunotherapy Response and Toxicity. Is the Future Bright? with Dr Claire Pallas
Episode 113: The role of Genomics and Genetics in predicting Immunotherapy Response and Toxicity Real World Application with Dr Claire Pallas
Episode 112: The role of Genomics and Genetics in predicting Immunotherapy Response and Toxicity Demystified with Dr Claire Pallas
Episode 111: A special episode to Celebrate Melanoma Focus 2024: TIL Therapy - The Future with ESMO Lifetime Achievement Award Winner 2024 Professor John Haanen Final Part
Episode 110: A special episode to Celebrate Melanoma Focus 2024: TIL Therapy - Demystified with ESMO Lifetime Achievement Award Winner 2024 Professor John Haanen Part 1
Episode 109: Potential Future application of the EpiSwitch Prediction Tool with Oxford BioDynamics Dr Ryan Mathis and Dr Bartu Ahiska
Episode 108: Practical Application in UK EpiSwitch Prediction Tool with Oxford BioDynamics Dr Ryan Mathis and Dr Bartu Ahiska
Episode 107: Can we predict response to immunotherapy? Validated and Available for Clinical Use - EpiSwitch Prediction Tool with Oxford BioDynamics Dr Ryan Mathis and Dr Bartu Ahiska
Episode 106: Practical Applications of the Microbiome Explored with CEO of Microbiotica Final Part - Tim Sharpington
Episode 105: Practical Applications of the Microbiome Explored with CEO of Microbiotica Part 2 - Tim Sharpington
Episode 104: Practical Applications of the Microbiome Explored with CEO of Microbiotica - Tim Sharpington
Episode 103: Gastro Toxicities from a Gastro perspective with Professor Nick Powell
Episode 102: Final Special Episode with An Oncology Superhero to Celebrate reaching the Hundredth Episode of The Immunobuddies - Melanoma with Late, Great, Professor Jeffrey S. Weber
Episode 101: A Special Episode with An Oncology Superhero to Celebrate reaching the Hundredth Episode of the Immunobuddies - Renal Cancer with Professor Tom Powles Final Part
Episode 100: A Special Episode with An Oncology Superhero to Celebrate the Hundredth Episode of the Immunobuddies - Renal Cancer with Professor Tom Powles
Episode 99: Role of Different Steroid Preparations and Administration in Refractory Toxicities
Episode 98: The pharmacology of Steroids and how to dose in Refractory Toxicities
Episode 97: Hypersensitivity - what should we do in the real world? With Dr Dan Carr
Episode 96: Types of Hypersensitivity and Different Checkpoint Inhibitors with Dr Dan Carr
Episode 95: Overview and Biological Basis of Hypersensitivity with Dr Dan Carr
Episode 94: PRIDE Celebration Part 3 Immunotherapy treatment considerations for the LGBTQIA+ community with Dr Alison Berner
Episode 93: to PRIDE Celebration Part 2 exploring medical considerations for the LGBTQIA+ community with Dr Alison Berner
Episode 92: PRIDE Celebration SPECIAL Podcast LGBTQIA+ (Overview for HCP's) with Dr Alison Berner (Specialist in Adult Gender Identity Medicine)
Episode 91: Lung Cancer (NSCLC) Final Part - The role of Immunotherapy with Dr Adam Januszewski
Episode 90: Lung Cancer (NSCLC) The role for Immunotherapy part 2 with Dr Adam Januszewski
Episode 89: Lung Cancer (NSCLC) The role of Immunotherapy with Dr Adam Januszewski
Episode 88: Head and Neck Cancer - Future role of Immunotherapy with Professor Kevin Harrington
Episode 87: Head and Neck Cancer - Overview and role of Immunotherapy with Professor Kevin Harrington
Episode 86: Oncolytic Viruses Demystified - is the Future bright? with Professor Kevin Harrington
Episode 85: Oncolytic Viruses Demystified - Real Life Clinical Application with Professor Kevin Harrington
Episode 84: Oncolytic Viruses Demystified - A Simplified Overview with Professor Kevin Harrington
Episode 83: IO and radiotherapy Final Part Practical Application with Professor Kevin Harrington
Episode 82: Part 2 - The role of Radiotherapy in enhancing the immune response with Professor Kevin Harrington
Episode 81: Abscopal effect, real or imagined? The role of Radiotherapy in enhancing the immune response with Professor Kevin Harrington
Episode 80: Immunology Final Part with Professor Mark Coles - The Future
Episode 79 Immunology Part 2 Clinical Application with Professor Mark Coles
Episode 78: Overview of Immunology (Getting to grips with the basic science that underpins immunotherapy) with Professor Mark Coles
Episode 77: Fatigue - Chronic Causes and Fatigue Bundle
Episode 76: Fatigue - Subacute Causes
Episode 75: Fatigue - Acute Causes
Episode 74: Fatigue - Definition and Approach
Episode 73: REFINE Trial with Dr Sophie Merrick and how to get involved - https://refine.mrcctu.ucl.ac.uk/
Episode 72: Dose, Frequency and Duration of Immunotherapy Part 2 with Cancer Research UK Clinical Fellow Dr Sophie Merrick
Episode 71: Dose, Frequency and Duration of Immunotherapy with Cancer Research UK Clinical Fellow Dr Sophie Merrick
Episode 70: What is next for the Microbiome? Future Practical Implications for Patient Care - FMT and Beyond with Melanoma Institute Australia and The University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan
Episode 69: The Practical Implications of the Microbiome for Patient Care with Melanoma Institute Australia and University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan
Episode 68: The Microbiome with Melanoma Institute Australia and University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan
Episode 67: Cancer Vaccines with Professor Lennard Lee - A silver lining of the pandemic
Episode 66: Influence of Genome and Cytokines (IL7) on Immunotherapy Toxicity with Dr Robert Watson
Episode 65: Dermatological (Skin Toxicities) Complex and Tricky Toxicities Final Part
Episode 64: Dermatological (Skin Toxicities) Complex and Tricky Toxicities
Episode 63: Dermatological (Skin Toxicities) Severe
Episode 62: Dermatological (Skin Toxicities) - Overview
Episode 61: Patient Podcast Number 6 Immunotherapy with Imogen Llewellyn. Q35-44 (see description) Immunotherapy- what did they say? Adjuvant?!? Medical jargon demystified!
Episode 60: Patient Podcast Number 5 Immunotherapy with Imogen Llewellyn.Q25-34 (see description) how will immunotherapy impact me and my family? .
Episode 59: Patient Podcast Number 4 Immunotherapy with Imogen Llewellyn. Q19-24 (see description). During and after Immunotherapy – I have so many questions about my treatment journey, potential side effects and after-care?
Episode 58: Patient Podcast Number 3 Immunotherapy with Imogen Llewellyn. Q15-18 (see description) Immunotherapy – My family, friends and career are important to me, can you advise?
Episode 57: Patient Podcast Number 2 Immunotherapy with Imogen Llewellyn. Q6-14 (see description). During immunotherapy – Side effects explained - Can I talk to someone for advice?
Episode 56: Patient Podcast Number 1 Immunotherapy with Imogen Llewellyn. Q1-5 (see description). Fundamentals of Immunotherapy
Episode 55: Management of Organ Transplant Patients with Dr Glenn Hanna Associate Professor Harvard Boston
Episode 54: Management of Organ Transplant Patients (CONTRAC -1) with Dr Glenn Hanna Associate Professor Harvard Boston
Episode 53: Pneumonitis dilemmas with Dr Ricardo Jose Respiratory Physician at the Royal Brompton
Episode 52: Role of radiology in managing Pneumonitis with Dr Ricardo Jose Respiratory Physician at the Royal Brompton
Episode 51: Launch of the I-O Clinical Network (IOCN) Let the fun begin!
Episode 50: Faecal Transplantation and Microbiome in Colitis Management - Dr Mimi Wang MD Anderson Texas
Episode 49: Refractory Colitis Management Discussion of Biologics - Dr Mimi Wang MD Anderson Texas
Episode 48: HIV and Checkpoint Inhibitors with Dr Rafeh Naqash Associate Professor at the Stephenson Cancer Center Oklahoma
Episode 47: Type 1 Diabetes/DKA and other Diabetes Dilemmas
Episode 46: Type 1 Diabetes/DKA with Checkpoint Inhibitor Immunotherapy
Episode 45: Immunotherapy for Medical Students part 2 - with Menna Aleman and Niamh Clarke
Episode 44: Immunotherapy for Medical Students - with Menna Aleman and Niamh Clarke
Episode 43: Endocrinology Hypophysitis Management
Episode 42: Endocrinology Hypophysitis
Episode 14: (the missing one!) Cardiotoxicities with Dr Rebecca Dobson
Episode 41: Advanced Therapies in Solid Tumours with Dr Andrew Furness CAR-T and T Cell Receptor
Episode 40: Advanced Therapies with Dr Andrew Furness Royal Marsden Hospital - Overview and Tumour Infiltrating Lymphocytes (TILs) Explained
Episode 39: Metastatic Melanoma - Future Immunotherapy 21/07/2023
Episode 38: Metastatic Melanoma - Current Role of Immunotherapy 14/07/2023
Episode 37: Primary Care Part 2 - Immunotherapy What is it and what does Primary care need to know? Macmillan Clinical Advisor for Wales - Dr Elise Lang
Episode 36: Primary Care - Immunotherapy Introduction for Primary Care Teams with Macmillan Clinical Advisor for Wales Dr Elise Lang
Episode 35: IO/TKI - Part 2
Episode 34: IO/TKI
Episode 33: Rheumatology - Sjögren's Part 2
Episode 32: Rheumatology - Sjögren's Part 1
Episode 31: Neurology - with Dr Mark Willis Guillain Barre Syndrome Part 3
Episode 30: Neurology - With Dr Mark Willis Guillain-Barre Syndrome GBS Part 2
Episode 29: Neurology - With Dr Mark Willis Guillain-Barre Syndrome GBS Part 1
Episode 28 : Rheumatology - Myositis and Dermatomyositis 12/05/2023
Episode 27: Rheumatology - Polymyalgia Rheumatica and GCA 05/05/2023
Episode 26: Rheumatology - Inflammatory Arthropathy and Rheumatoid Arthritis Part 2 28/04/2023
Episode 25: Rheumatology - Inflammatory Arthropathy and Rheumatoid Arthritis 28/04/2023
Episode 24: Ocular - Anterior Uveitis and Dry Eyes with Dr Nima Ghadiri 21/04/2023
Episode 23: Neurology - Encephalitis with Dr Mark Willis 14/04/2023
Episode 22: Immunonewbies Part 2 - Introduction to Immunotherapy 07/04/2023
Episode 21: Immunonewbies Part 1 - Introduction to Immunotherapy 07/04/2023
Episode 20: Nephritis Part 3 31/03/2023
Episode 19: Nephritis Part 2 31/03/2023
Episode 18: Nephritis Part 1 31/03/2023
Episode 17: Hepatitis Part 3 17/03/2023
Episode 16: Hepatitis Part 2 17/03/2023
Episode 15: Hepatitis Part 1 17/03/2023
Episode 13 Cardiotoxicities Part 3 25/02/2023
Episode 12 Cardiotoxicities Part 2 25/02/2023
Episode 11 Cardiotoxicities Part 1 25/02/2023
Episode 10: Pneumonitis Part 3 12/02/2023
Episode 9: Pneumonitis Part 2 12/02/2023
Episode 8: Pneumonitis Part 1 12/02/2023
Episode 7: Colitis Part 3 10/02/2023
Episode 6: Colitis Part 2 10/02/2023
Episode 5: Colitis Part 1 10/02/2023
Episode 4: Myasthenia Gravis 03/02/2023
Episode 3: I-O Clinical Network (IOCN) 03/02/2023
Episode 2: Thyroid Dysfunction 27/01/2023
Episode 1: Adrenal Insufficiency 27/01/2023